Page last updated: 2024-10-31

mexiletine and Anemia, Sickle Cell

mexiletine has been researched along with Anemia, Sickle Cell in 1 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kadouh, NK1
Lang, S1
Shamoun, M1
Scott, EL1
Singh, SA1
Smith, MA1

Other Studies

1 other study available for mexiletine and Anemia, Sickle Cell

ArticleYear
Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:8

    Topics: Anemia, Sickle Cell; Autism Spectrum Disorder; Humans; Mexiletine; Pain, Intractable

2022